The historic rise of Viagra has consistently remained a example of pharmaceutical success, however its future within the broader market now raises questions about long-term returns . Alternative versions are eroding patent protection , leading to concerns that investing in companies heavily reliant to Viagra's once-dominant standing could be a prob